Comparative Effectiveness of Total Neoadjuvant Therapy Versus Standard Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
- 21 January 2021
- journal article
- research article
- Published by Elsevier BV in Clinical Colorectal Cancer
- Vol. 20 (2), 121-129
- https://doi.org/10.1016/j.clcc.2021.01.001
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Complete Neoadjuvant Treatment for Rectal CancerAmerican Journal of Clinical Oncology, 2017
- PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancerAnnals of Oncology, 2016
- Neoadjuvant Treatment Strategies for Locally Advanced Rectal CancerClinical Oncology, 2015
- Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trialAnnals of Oncology, 2015
- No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT)Radiotherapy and Oncology, 2014
- Propensity Score Methods for Confounding Control in Nonexperimental ResearchCirculation: Cardiovascular Quality and Outcomes, 2013
- Addition of Bevacizumab to XELOX Induction Therapy Plus Concomitant Capecitabine-Based Chemoradiotherapy in Magnetic Resonance Imaging–Defined Poor-Prognosis Locally Advanced Rectal Cancer: The AVACROSS StudyThe Oncologist, 2011
- The TME Trial After a Median Follow-up of 6 YearsAnnals of Surgery, 2007
- Chemotherapy with Preoperative Radiotherapy in Rectal CancerThe New England Journal of Medicine, 2006
- Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal CancerJournal of Clinical Oncology, 2006